- Save the Children launch website designed with CORU's help
- Attempts at surgical removal are of no benefit to asbestos cancer sufferers finds trial led by CORU's Tom Treasure
- CORU's work shows effects of selective citation on surgical practice
- Pandemic flu countermeasure work published in Vaccine
- Editorial praises CORU's simple risk stratification model
- Tom Treasure's talk is ranked among top three presentations
- The Ekjut trial in India is selected as Trial of the Year!
- Christos Vasilakis gives keynote lecture at Young OR 17 conference
- CORU informs national policy on pandemic flu
- CORU work examines the foundations of triage
- Christina Pagel gives invited talk at RCM conference
- Martin Utley gives invited talk at the MASHNET workshop
- Making sense of statistics
- UCL helps engineer to heal his own heart
- Christina Pagel has paper published in The Lancet
- Martin Utley promoted to professor
- Professor Tom Treasure attends NICE International conference
- Citation for Steve Gallivan
- NCEPOD report highlights concerns over chemotherapy
- CORU 25 year celebration
- Marfan aortic aneurysm: Golesworthy wins Healthcare Award
- CORU projections of skilled birth attendance rates in world's poorest regions published
- CORU's Skilled Birth Attendance paper is a BMC Highly Accessed paper!
- CORU's visual outcome monitoring tool (VLAD) goes global!
- Number of people living with cancer set to increase significantly
- CORU article highlights challenges in implementing modelling toolkits
- Health financing website receives positive feedback!
- Is surgery to remove secondary cancer always a good thing?
- Sonya Crowe awarded Improvement Science Fellowship by the Health Foundation!
- CORU work helps child heart teams get clearer picture of their results
Pandemic flu countermeasure work published in Vaccine
21 June 2011
CORU's work with the UK Department of Health last year has resulted in a paper1 published in Vaccine. One of the major complications of flu is pneumonia and it was thought that vaccinating the population against pneumococcal pneumonia at the start of a pandemic might prevent deaths due to complications of flu. We built a mathematical model to investigate the potential effect of such a policy using a variety of estimates over the efficacy of the pneumonia vaccine, the virulence of the flu and the achievable coverage of such a vaccination programme. We found that there were substantial reductions in deaths only under specific circumstances - a virulent flu where most complications were due to pneumococcal pneumonia.
1. Crowe S, Utley M, Walker G, Grove P, Pagel C (2011)
A model to evaluate mass vaccination against pneumococcus as a countermeasure against pandemic influenza